10401 N. Meridian Street, Suite 225, Carmel, IN, 46290, United States
Biopharmaceutical company developing TYK2 inhibitors for inflammatory disea
Total Raised
$67 M
Rounds
2
Links
Verticals
Series B
Feb 2024
$30M
Series A
Sep 2022
$37M
Scott Byrd
CEO
Daniel Estes
Founder & Director
Anjali Pandey
SVP, Medicinal Chemistry
Imran Babar
Chief Business Officer
